Bepotastine

Evidence Level: N/A

Predicted Indications: 0

---

Table of Contents

1. Bepotastine
   1. Pharmacist Assessment Report
   2. Bepotastine: Known uses and market status in India
   3. Summary
   4. Quick overview
   5. Known uses among the model’s candidates
      1. Approved (supported by a licence or label)
      2. Related to an approved indication (same disease category)
      3. Relations recorded in the knowledge graph (no approval found)
   6. India Market Information
   7. Safety Considerations
   8. Disclaimer

---

Pharmacist Assessment Report

Bepotastine: Known uses and market status in India

Summary

The TxGNN model’s candidates for Bepotastine (score ≥ 0.99) are all known uses, so there is currently no new predicted indication. The one candidate that can be traced to a source, allergic urticaria, is supported by the official label.

Quick overview

Item	Content
New predicted indications	None (all traceable model candidates are known uses)
Known uses among model candidates	1
Evidence level	Not applicable
India Market Status	Listed in a compiled Indian medicine price dataset (at least 20) – CDSCO approval status is not included in this data
Number of Listed Products	at least 20

Known uses among the model’s candidates

Approved (supported by a licence or label)

Indication	Source
allergic urticaria	official label (curated); approved indication: urticaria

Related to an approved indication (same disease category)

Indication	Approved category
none	none

Relations recorded in the knowledge graph (no approval found)

Indication
none

India Market Information

Licence	Product	Dosage form	Status
26248	Beipos Tablet	strip of 10 tablets	Valid
121241	Lupin Bepogra Tablet	strip of 10 tablets	Valid
26966	Bepomac Tablet	strip of 10 tablets	Valid
30093	Bepotosin Eye Drop	bottle of 5 ml Ophthalmic Solution	Valid
176085	Prustat Tablet	strip of 10 tablets	Valid
26168	Bepozal Tablet	strip of 10 tablets	Valid
162667	Optistat Eye Drop	bottle of 5 ml Eye Drop	Valid
26714	Beporest Eye drop	bottle of 5 ml Ophthalmic Solution	Valid
163224	Optihist Bang 1.5% Eye Drop	bottle of 5 ml Eye Drop	Valid
59250	Dabfit Eye Drop	bottle of 5 ml Ophthalmic Solution	Valid
28179	Bepobesil 1.5% Eye Drop	bottle of 5 ml Eye Drop	Valid
4583	Analar Gold 1.5% Eye Drop	packet of 5 ml Eye Drop	Valid
25870	Beipos Eye Drop	bottle of 5 ml Ophthalmic Solution	Valid
16475	Allerbep 1.5% Eye Drop	bottle of 5 ml Eye Drop	Valid
26177	Beposurge Eye Drop	bottle of 5 ml Ophthalmic Solution	Valid
247377	Zyclear Eye Drop	packet of 5 ml Ophthalmic Solution	Valid
26952	Botas Ophthalmic Solution	bottle of 5 ml Ophthalmic Solution	Valid
29024	Bepoday Eye Drop	bottle of 5 ml Ophthalmic Solution	Valid
25986	Betoact Eye Drop BAK Free	bottle of 5 ml Eye Drop	Valid
27003	Bepomax 1.5% Eye Drop	bottle of 5 ml Eye Drop	Valid

Only part of the licence list is held in the data; the list may be incomplete.

Safety Considerations

Please refer to the package insert for safety information.

One published case report describes hypersensitivity (urticaria) to bepotastine with cross-reactivity to other antihistamines. This is rare, but relevant for patients with a history of antihistamine intolerance.

Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.

---